Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase

Soichi Noguchi, Suree Jianmongkol, Andrew T. Bender, Yasuhiko Kamada, Damon R. Demady, Yoichi Osawa

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Guanabenz, a metabolism-based irreversible inactivator of neuronal nitric-oxide synthase (nNOS) in vitro, causes the loss of immunodetectable nNOS in vivo. This process is selective in that the slowly reversible inhibitor N(G)-nitro-L-arginine did not decrease the levels of nNOS in vivo. To better understand the mechanism for the loss of nNOS protein in vivo, we have investigated the effects of guanabenz and N(G)-nitro-L-arginine in HEK 293 cells stably transfected with the enzyme. We show here that guanabenz, but not N(G)-nitro-L-arginine, caused the inactivation and loss of nNOS protein in the HEK 293 cells. In studies with cycloheximide or in pulse-chase experiments with [35S]methionine, we demonstrate that the loss of nNOS was due in large part to enhanced proteolysis of the protein with the half-life decreasing by one-half from 20 to 10 h. Other metabolism-based irreversible inactivators to nNOS, N(G)-methyl-L-arginine, and N5-(1-iminoethyl)-L- ornithine, but not the reversible inhibitor 7-nitroindazole (7-NI), caused a similar decrease in the half-life of nNOS. Proteasomal inhibitors, lactacystin, Cbz-leucine-leucine-leucinal, and N-acetyl-leucine-leucine- norleucinal, but not the lysosomal protease inhibitor leupeptin, were found to effectively inhibit the proteolytic degradation of nNOS. Thus we have shown for the first time that the irreversible inactivators of nNOS, perhaps through covalent alteration of the enzyme, enhance the proteolytic turnover of the enzyme by a mechanism involving the proteasome.

Original languageEnglish
Pages (from-to)2376-2380
Number of pages5
JournalJournal of Biological Chemistry
Volume275
Issue number4
DOIs
Publication statusPublished - Jan 28 2000
Externally publishedYes

Fingerprint

Guanabenz
Nitric Oxide Synthase Type I
Degradation
Leucine
Arginine
HEK293 Cells
Metabolism
Half-Life
Enzymes
Proteolysis
Proteins
Proteasome Endopeptidase Complex
Cycloheximide
Protease Inhibitors
Methionine
Peptide Hydrolases

ASJC Scopus subject areas

  • Biochemistry

Cite this

Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase. / Noguchi, Soichi; Jianmongkol, Suree; Bender, Andrew T.; Kamada, Yasuhiko; Demady, Damon R.; Osawa, Yoichi.

In: Journal of Biological Chemistry, Vol. 275, No. 4, 28.01.2000, p. 2376-2380.

Research output: Contribution to journalArticle

Noguchi, Soichi ; Jianmongkol, Suree ; Bender, Andrew T. ; Kamada, Yasuhiko ; Demady, Damon R. ; Osawa, Yoichi. / Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase. In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 4. pp. 2376-2380.
@article{426a61ee9ee24b13b037aba45b028a2f,
title = "Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase",
abstract = "Guanabenz, a metabolism-based irreversible inactivator of neuronal nitric-oxide synthase (nNOS) in vitro, causes the loss of immunodetectable nNOS in vivo. This process is selective in that the slowly reversible inhibitor N(G)-nitro-L-arginine did not decrease the levels of nNOS in vivo. To better understand the mechanism for the loss of nNOS protein in vivo, we have investigated the effects of guanabenz and N(G)-nitro-L-arginine in HEK 293 cells stably transfected with the enzyme. We show here that guanabenz, but not N(G)-nitro-L-arginine, caused the inactivation and loss of nNOS protein in the HEK 293 cells. In studies with cycloheximide or in pulse-chase experiments with [35S]methionine, we demonstrate that the loss of nNOS was due in large part to enhanced proteolysis of the protein with the half-life decreasing by one-half from 20 to 10 h. Other metabolism-based irreversible inactivators to nNOS, N(G)-methyl-L-arginine, and N5-(1-iminoethyl)-L- ornithine, but not the reversible inhibitor 7-nitroindazole (7-NI), caused a similar decrease in the half-life of nNOS. Proteasomal inhibitors, lactacystin, Cbz-leucine-leucine-leucinal, and N-acetyl-leucine-leucine- norleucinal, but not the lysosomal protease inhibitor leupeptin, were found to effectively inhibit the proteolytic degradation of nNOS. Thus we have shown for the first time that the irreversible inactivators of nNOS, perhaps through covalent alteration of the enzyme, enhance the proteolytic turnover of the enzyme by a mechanism involving the proteasome.",
author = "Soichi Noguchi and Suree Jianmongkol and Bender, {Andrew T.} and Yasuhiko Kamada and Demady, {Damon R.} and Yoichi Osawa",
year = "2000",
month = "1",
day = "28",
doi = "10.1074/jbc.275.4.2376",
language = "English",
volume = "275",
pages = "2376--2380",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase

AU - Noguchi, Soichi

AU - Jianmongkol, Suree

AU - Bender, Andrew T.

AU - Kamada, Yasuhiko

AU - Demady, Damon R.

AU - Osawa, Yoichi

PY - 2000/1/28

Y1 - 2000/1/28

N2 - Guanabenz, a metabolism-based irreversible inactivator of neuronal nitric-oxide synthase (nNOS) in vitro, causes the loss of immunodetectable nNOS in vivo. This process is selective in that the slowly reversible inhibitor N(G)-nitro-L-arginine did not decrease the levels of nNOS in vivo. To better understand the mechanism for the loss of nNOS protein in vivo, we have investigated the effects of guanabenz and N(G)-nitro-L-arginine in HEK 293 cells stably transfected with the enzyme. We show here that guanabenz, but not N(G)-nitro-L-arginine, caused the inactivation and loss of nNOS protein in the HEK 293 cells. In studies with cycloheximide or in pulse-chase experiments with [35S]methionine, we demonstrate that the loss of nNOS was due in large part to enhanced proteolysis of the protein with the half-life decreasing by one-half from 20 to 10 h. Other metabolism-based irreversible inactivators to nNOS, N(G)-methyl-L-arginine, and N5-(1-iminoethyl)-L- ornithine, but not the reversible inhibitor 7-nitroindazole (7-NI), caused a similar decrease in the half-life of nNOS. Proteasomal inhibitors, lactacystin, Cbz-leucine-leucine-leucinal, and N-acetyl-leucine-leucine- norleucinal, but not the lysosomal protease inhibitor leupeptin, were found to effectively inhibit the proteolytic degradation of nNOS. Thus we have shown for the first time that the irreversible inactivators of nNOS, perhaps through covalent alteration of the enzyme, enhance the proteolytic turnover of the enzyme by a mechanism involving the proteasome.

AB - Guanabenz, a metabolism-based irreversible inactivator of neuronal nitric-oxide synthase (nNOS) in vitro, causes the loss of immunodetectable nNOS in vivo. This process is selective in that the slowly reversible inhibitor N(G)-nitro-L-arginine did not decrease the levels of nNOS in vivo. To better understand the mechanism for the loss of nNOS protein in vivo, we have investigated the effects of guanabenz and N(G)-nitro-L-arginine in HEK 293 cells stably transfected with the enzyme. We show here that guanabenz, but not N(G)-nitro-L-arginine, caused the inactivation and loss of nNOS protein in the HEK 293 cells. In studies with cycloheximide or in pulse-chase experiments with [35S]methionine, we demonstrate that the loss of nNOS was due in large part to enhanced proteolysis of the protein with the half-life decreasing by one-half from 20 to 10 h. Other metabolism-based irreversible inactivators to nNOS, N(G)-methyl-L-arginine, and N5-(1-iminoethyl)-L- ornithine, but not the reversible inhibitor 7-nitroindazole (7-NI), caused a similar decrease in the half-life of nNOS. Proteasomal inhibitors, lactacystin, Cbz-leucine-leucine-leucinal, and N-acetyl-leucine-leucine- norleucinal, but not the lysosomal protease inhibitor leupeptin, were found to effectively inhibit the proteolytic degradation of nNOS. Thus we have shown for the first time that the irreversible inactivators of nNOS, perhaps through covalent alteration of the enzyme, enhance the proteolytic turnover of the enzyme by a mechanism involving the proteasome.

UR - http://www.scopus.com/inward/record.url?scp=0034723394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034723394&partnerID=8YFLogxK

U2 - 10.1074/jbc.275.4.2376

DO - 10.1074/jbc.275.4.2376

M3 - Article

VL - 275

SP - 2376

EP - 2380

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -